Study of serum lipid profile in patients with oral submucous fibrosis and oral squamous cell carcinoma and their comparative analysis

Khyalia, Sangeeta

doi:10.52547/rabms.8.2.90

Volume 8, Issue 2 (5-2022) Journal of Research in Applied and Basic Medical Sciences 2022, 8(2): 90-96 | Back to browse issues page

‎ 10.52547/rabms.8.2.90

Mendeley

Zotero

RefWorks

Khyalia S. Study of serum lipid profile in patients with oral submucous fibrosis and oral squamous cell carcinoma and their comparative analysis. Journal of Research in Applied and Basic Medical Sciences 2022; 8 (2) :90-96
URL: http://ijrabms.umsu.ac.ir/article-1-185-en.html

Study of serum lipid profile in patients with oral submucous fibrosis and oral squamous cell carcinoma and their comparative analysis

Sangeeta Khyalia ^*

Assistant Professor, Department of Biochemistry, SMS Medical College and Hospital, Jaipur, India , sangeetakhyalia1@gmail.com

Abstract: (1125 Views)

Background & Aims: The aim of this study was to evaluate serum lipid profile and compare their levels between the patients with oral submucous fibrosis (OSMF) and oral squamous cell carcinoma (OSCC).
Materials & Methods: This descriptive study was done in two groups of patients; OSMF and OSCC patients. There were forty-five participants in each group. Serum samples obtained from centrifugation of 12 hour fasting blood samples was analyzed by fully automated analyzer Beckman coulter AU-680 for estimation of the lipid levels (cholesterol, triglycerides (TGL), and high‑density lipids (HDL)) using colorimetric methods. Low‑density lipid (LDL) values were obtained by calculation.
Results: The comparison of lipid profile between Oral Submucous Fibrosis and Oral Carcinoma cases shows statistically significant results for TC, HDL and LDL.
Conclusion: The change in lipid levels may have an early diagnostic or prognostic role in oral premalignant and malignant lesions.

Keywords: Oral Submucous Fibrosis, Oral Squamous Cell Carcinoma, Serum Lipid Profile

Full-Text [PDF 441 kb] (486 Downloads)

Type of Study: orginal article | Subject: Special

References

1. Rahrovani F, Javanbakht MH, Ehsani AH, Esrafili A, Mohammadi H, Ghaedi E, et al. Erythrocyte membrane saturated fatty acids profile in newly diagnosed basal cell carcinoma patients. Clin Nutr ESPEN 2018; 23:107-11. [DOI:10.1016/j.clnesp.2017.11.007] [PMID]

2. Halton JM, Nazir DJ, McQueen MJ, Barr RD. Blood lipid profiles in children with acute lymphoblastic leukemia. Cancer 1998;83:379-84. https://doi.org/10.1002/(SICI)1097-0142(19980715)83:2<379::AID-CNCR24>3.0.CO;2-P [DOI:10.1002/(SICI)1097-0142(19980715)83:23.0.CO;2-P]

3. Allampallam K, Dutt D, Nair C, Shetty V, Mundle S, Lisak L, et al. The clinical and biologic significance of abnormal lipid profiles in patients with myelodysplastic syndromes. J Hematother Stem Cell Res 2000;9:247-55. [DOI:10.1089/152581600319469] [PMID]

4. Gilbert MS, Ginsberg H, Fagerstrom R, Brown WV. Characterization of hypocholesterolemia in myeloproliferative disease: Relation to disease manifestations and activity. Am J Med 1981;71:595-602. [DOI:10.1016/0002-9343(81)90212-6] [PMID]

5. Alexopoulos CG, Blatsios B, Avgerinos A. Serum lipids and lipoprotein disorders in cancer patients. Cancer 1987;60:3065-70. https://doi.org/10.1002/1097-0142(19871215)60:12<3065::AID-CNCR2820601234>3.0.CO;2-Q [DOI:10.1002/1097-0142(19871215)60:123.0.CO;2-Q] [PMID]

6. Tietz, N.W., Textbook of Clinical Chemistry, W.B. Saunders, 888, 1986. [URL]

7. CLSI, Interference Testing in Clinical Chemistry, EP7-A, 2002. [URL]

8. Young, D.S., Effects of Drugs on Clinical Laboratory Tests, 5th Edition, AACC Press, 2000. [PMID]

9. CLSI/NCCLS Evaluation of Precision Performance of Clinical Chemistry Devices, EP05-A, 1999.

10. R. Rajendran. Shafers Textbook of Oral Pathology, 5thed, Elsevier publication, 2006 143-167. [URL]

11. Mehta FS, Hamner JE. India: Jaypee Brothers Medical Pub (P) Ltd, Basic Dental Research Unit; 1993. Oral submucous fibrosis tobacco-related oral mucosal lesions in India; pp. 56-67.

12. Epstein JB, Zhang L, Rosin M. Advances in the diagnosis of oral premalignant and malignant lesions. J Can Dent Assoc 2002;68:617-21. [Google Scholar]

13. Shivakumar KM, Raje V, Kadashetti V. Prevalence of oral potentially malignant disorders (OPMD) in adults of Western Maharashtra, India: A cross-sectional study. J Cancer Res Ther [Epub ahead of print] [cited 2022 May 7]. [Google Scholar]

14. Misra V, Singh PA, Lal N, Agarwal P, Singh M. Changing pattern of oral cavity lesions and personal habits over a decade: Hospital based record analysis from Allahabad. Indian J Community Med 2009;34:321-5. [DOI:10.4103/0970-0218.58391] [PMID] [PMCID]

15. Singh MP, Kumar V, Agarwal A, Kumar R, Bhatt ML, Misra S. Clinico epidemiological study of oral squamous cell carcinoma: A tertiary care centre study in North India. J Oral Biol Craniofac Res 2016;6:31-4. [DOI:10.1016/j.jobcr.2015.11.002] [PMID] [PMCID]

16. Abdulla R, Adyanthaya S, Kini P, Mohanty V, D'Souza N, SubbannayyaY. Clinicopathological analysis of oral squamous cell carcinoma among the younger age group in coastal Karnataka, India: A retrospective study. J Oral Maxillofac Pathol 2018;22:180-7. [DOI:10.4103/jomfp.JOMFP_16_18] [PMID] [PMCID]

17. Tandon A, Bordoloi B, Jaiswal R, Srivastava A, Singh RB, Shafique U. Demographic and clinicopathological profile of oral squamous cell carcinoma patients of North India: A retrospective institutional study. SRM J Res Dent Sci 2018;9:114-8. [DOI:10.4103/srmjrds.srmjrds_21_18]

18. Kumar GK, Abidullah M, Elbadawi L, Dakhil S, Mawardi H. Epidemiological profile and clinical characteristics of oral potentially malignant disorders and oral squamous cell carcinoma: A pilot study in Bidar and Gulbarga Districts, Karnataka, India. J Oral Maxillofac Pathol 2019;23:90-6. [DOI:10.4103/0973-029X.273570] [PMID] [PMCID]

19. Jayasooriya PR, Pitakotuwage TN, Mendis BR, Lombardi T. Descriptive study of 896 oral squamous cell carcinomas from the only university based oral pathology diagnostic service in Sri Lanka. BMC Oral Health 2016;16:1. [DOI:10.1186/s12903-015-0139-y] [PMID] [PMCID]

20. Lohe VK, Degwekar SS, Bhowate RR, Kadu RP, Dangore SB. Evaluation of correlation of serum lipid profile in patients with oral cancer and precancer and its association with tobacco abuse. J Oral Pathol Med 2010;39:141-8. [DOI:10.1111/j.1600-0714.2009.00828.x] [PMID]

21. Chawda JG, Jain S, Patel HR, Chaduvula N, Patel K. The relationship between serum lipid levels and the risk of oral cancer. Indian J Med Paediatr Oncol 2011;32:34-7. [DOI:10.4103/0971-5851.81888] [PMID] [PMCID]

22. Chao Fu-Chuan, Efron Bradley, Wolf Paul. The possible prognostic usefulness of assessing serum proteins and cholesterol in malignancy. Can Res 1975;35:1223-9. https://doi.org/10.1002/1097-0142(197504)35:4<1223::AID-CNCR2820350429>3.0.CO;2-T [DOI:10.1002/1097-0142(197504)35:43.0.CO;2-T] [PMID]

23. Choi Min-ah, Kim Byung-Sick, Rina YU. Serum antioxidative levels and lipid peroxidation in gastric carcinoma patients. Cancer Letters 1999;136:89-93. [DOI:10.1016/S0304-3835(98)00312-7] [PMID]

24. Desai S, Batetta B, Pani P, et al. Altered pattern of lipid metabolism in patients with lung cancer. Oncology 1992;49: 436-41. [DOI:10.1159/000227088] [PMID]

25. Alexopoulos CG, Blatsios B, Avgerinos A. Serum lipids and lipoprotein disorders in cancer patients. Cancer 1987;60:3065-70. https://doi.org/10.1002/1097-0142(19871215)60:12<3065::AID-CNCR2820601234>3.0.CO;2-Q [DOI:10.1002/1097-0142(19871215)60:123.0.CO;2-Q] [PMID]